323 related articles for article (PubMed ID: 28223790)
1. Longitudinal changes in lung hyperinflation in COPD.
Park J; Lee CH; Lee YJ; Park JS; Cho YJ; Lee JH; Lee CT; Yoon HI
Int J Chron Obstruct Pulmon Dis; 2017; 12():501-508. PubMed ID: 28223790
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease.
Lee JS; Kim SO; Seo JB; Lee JH; Kim EK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Lee SW; Huh JW; Oh YM; Lee SD
Lung; 2013 Aug; 191(4):405-12. PubMed ID: 23715996
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD
J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal changes in handgrip strength, hyperinflation, and 6-minute walk distance in patients with COPD and a control group.
Felipe C; Bartolome C; Miguel D; Victor PP
Chest; 2015 Oct; 148(4):986-994. PubMed ID: 25996450
[TBL] [Abstract][Full Text] [Related]
5. Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.
Cardoso J; Coelho R; Rocha C; Coelho C; Semedo L; Bugalho Almeida A
Int J Chron Obstruct Pulmon Dis; 2018; 13():1105-1113. PubMed ID: 29670346
[TBL] [Abstract][Full Text] [Related]
6. The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease.
French A; Balfe D; Mirocha JM; Falk JA; Mosenifar Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():1305-12. PubMed ID: 26203237
[TBL] [Abstract][Full Text] [Related]
7. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
8. Not all measures of hyperinflation are created equal: lung structure and clinical correlates of gas trapping and hyperexpansion in COPD: the Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study.
Smith BM; Hoffman EA; Basner RC; Kawut SM; Kalhan R; Barr RG
Chest; 2014 Jun; 145(6):1305-1315. PubMed ID: 24481056
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
Ulubay G; Görek A; Savaş S; Oner Eyüboğlu F
Tuberk Toraks; 2005; 53(4):340-6. PubMed ID: 16456732
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Positive Expiratory Pressure Therapy on Hyperinflation in Patients With COPD.
de Macedo JRFF; Conceiçãodos Dos Santos ED; Reychler G; Poncin W
Respir Care; 2024 Feb; 69(3):366-375. PubMed ID: 38416659
[TBL] [Abstract][Full Text] [Related]
11. Tiotropium and simplified detection of dynamic hyperinflation.
Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N
Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081
[TBL] [Abstract][Full Text] [Related]
12. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD.
Vassaux C; Torre-Bouscoulet L; Zeineldine S; Cortopassi F; Paz-Díaz H; Celli BR; Pinto-Plata VM
Eur Respir J; 2008 Nov; 32(5):1275-82. PubMed ID: 18550609
[TBL] [Abstract][Full Text] [Related]
13. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
14. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
15. Inspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPD.
Ramon MA; Ferrer J; Gimeno-Santos E; Donaire-Gonzalez D; Rodríguez E; Balcells E; de Batlle J; Benet M; Guerra S; Sauleda J; Ferrer A; Farrero E; Gea J; Barberà JA; Agustí A; Rodriguez-Roisin R; Antó JM; Garcia-Aymerich J;
Respirology; 2016 Apr; 21(3):476-82. PubMed ID: 26714424
[TBL] [Abstract][Full Text] [Related]
16. Different therapeutic responses in chronic obstructive pulmonary disease subgroups.
Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1104-10. PubMed ID: 21740676
[TBL] [Abstract][Full Text] [Related]
17. Physical activity and the frequency of acute exacerbations in patients with chronic obstructive pulmonary disease.
Schönmann M; Sievi NA; Clarenbach CF; Brack T; Brutsche M; Frey M; Irani S; Leuppi JD; Ruediger J; Senn O; Thurnheer R; Kohler M
Lung; 2015 Feb; 193(1):63-70. PubMed ID: 25503750
[TBL] [Abstract][Full Text] [Related]
18. Effects of bronchodilators on dynamic hyperinflation following hyperventilation in patients with COPD.
Fujimoto K; Yoshiike F; Yasuo M; Kitaguchi Y; Urushihata K; Kubo K; Honda T
Respirology; 2007 Jan; 12(1):93-9. PubMed ID: 17207032
[TBL] [Abstract][Full Text] [Related]
19. An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD.
Ozgür ES; Nayci SA; Özge C; Taşdelen B
Respir Care; 2012 Sep; 57(9):1452-9. PubMed ID: 22348294
[TBL] [Abstract][Full Text] [Related]
20. A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD.
Cazzola M; Rogliani P; Curradi G; Segreti A; Ciaprini C; Pezzuto G; Saltini C
Pulm Pharmacol Ther; 2009 Dec; 22(6):522-5. PubMed ID: 19481169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
